相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
Alice Mariottini et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Immunological consequences of immune reconstitution therapy in multiple sclerosis: A systematic review
Johann Sellner et al.
AUTOIMMUNITY REVIEWS (2020)
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway
Silje Agnethe Stokke Kvistad et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis
Kristina M. Harris et al.
JCI INSIGHT (2020)
Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
I Dekker et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
Jan D. Lünemann et al.
Nature Reviews Neurology (2019)
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis A Randomized Clinical Trial
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
John J. Moore et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
Yvonne Naegelin et al.
JAMA NEUROLOGY (2019)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Paolo A. Muraro et al.
NATURE REVIEWS NEUROLOGY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A. Nash et al.
NEUROLOGY (2017)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A meta-analysis
Maria Pia Sormani et al.
NEUROLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Paolo A. Muraro et al.
JAMA NEUROLOGY (2017)
Long-Term Evolution of Multiple Sclerosis Disability in the Treatment Era
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2016)
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
Harold L. Atkins et al.
LANCET (2016)
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
Daniela Curro et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Aggressive multiple sclerosis: proposed definition and treatment algorithm
Carolina A. Rush et al.
NATURE REVIEWS NEUROLOGY (2015)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Giovanni L. Mancardi et al.
NEUROLOGY (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
Daniela Curro et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
T cell repertoire following autologous stem cell transplantation for multiple sclerosis
Paolo A. Muraro et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Joachim Burman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity
Imtiaz M. Mumtaz et al.
JOURNAL OF AUTOIMMUNITY (2012)
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
G. L. Mancardi et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Long-term results of stem cell transplantation for MS A single-center experience
A. Fassas et al.
NEUROLOGY (2011)
Professional Memory CD4+ T Lymphocytes Preferentially Reside and Rest in the Bone Marrow
Koji Tokoyoda et al.
IMMUNITY (2009)
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
Massimiliano Di Filippo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
分享论文
